Question 1

Does Trexquant Investment own ABCL stock?

Accepted Answer

No. Trexquant Investment exited its ABCL (Abcellera Biologics) position in Q4 2023. Its Q3 2023 13F listed 272,158 shares worth $1.3M.

Question 2

How many shares of ABCL does Trexquant Investment own?

Accepted Answer

None since Q4 2023, when Trexquant Investment exited the position. Its Q3 2023 13F listed 272,158 shares worth $1.3M.

Question 3

What is Trexquant Investment's ABCL position worth?

Accepted Answer

Trexquant Investment's ABCL position was worth $1.3M in its Q3 2023 13F, before the exit in Q4 2023.

Question 4

Is Trexquant Investment buying or selling ABCL?

Accepted Answer

In Q4 2023, Trexquant Investment exited its entire ABCL position.

Question 5

When did Trexquant Investment first buy ABCL?

Accepted Answer

Trexquant Investment first reported ABCL in its Q2 2021 13F and listed it in 7 quarterly 13F filings.